Physiological Effect: Increased Cytokine Activity
✉ Email this page to a colleague
Drugs with Physiological Effect: Increased Cytokine Activity
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | ALDARA | imiquimod | CREAM;TOPICAL | 020723-001 | Feb 27, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Padagis Israel | IMIQUIMOD | imiquimod | CREAM;TOPICAL | 078837-001 | Sep 7, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Taro | IMIQUIMOD | imiquimod | CREAM;TOPICAL | 200173-001 | Apr 15, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Taro | IMIQUIMOD | imiquimod | CREAM;TOPICAL | 205971-001 | Jan 26, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Glenmark Pharms Inc | IMIQUIMOD | imiquimod | CREAM;TOPICAL | 201994-001 | Mar 6, 2012 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |